Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT00643747
Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis
Safety Study of RPE65 Gene Therapy to Treat Leber Congenital Amaurosis
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2007-01-01
- Closing Date: 2014-12-01
Criteria
Children: No
Adults: No
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
